{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:02:50Z","timestamp":1793689370143,"version":"4.5.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Women and Children Health Care Association of Shandong","award":["SFYXH-2023Y017"],"award-info":[{"award-number":["SFYXH-2023Y017"]}]},{"name":"the Women and Children Health Care Association of Shandong","award":["SFYXH-2023Y017"],"award-info":[{"award-number":["SFYXH-2023Y017"]}]},{"name":"the Women and Children Health Care Association of Shandong","award":["SFYXH-2023Y017"],"award-info":[{"award-number":["SFYXH-2023Y017"]}]},{"name":"the Women and Children Health Care Association of Shandong","award":["SFYXH-2023Y017"],"award-info":[{"award-number":["SFYXH-2023Y017"]}]},{"name":"the Women and Children Health Care Association of Shandong","award":["SFYXH-2023Y017"],"award-info":[{"award-number":["SFYXH-2023Y017"]}]},{"name":"the Women and Children Health Care Association of Shandong","award":["SFYXH-2023Y017"],"award-info":[{"award-number":["SFYXH-2023Y017"]}]},{"name":"the Shandong Provincial Center for ADR Monitoring, China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00228-025-03807-9","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T18:08:44Z","timestamp":1739470124000},"page":"507-523","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Adjunctive treatment for pediatric focal epilepsy: a systematic review"],"prefix":"10.1007","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6352-2316","authenticated-orcid":false,"given":"Siru","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5945-4363","authenticated-orcid":false,"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"3807_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1684\/epd.2015.0736","volume":"17","author":"P Camfield","year":"2015","unstructured":"Camfield P, Camfield C (2015) Incidence, prevalence and aetiology of seizures and epilepsy in children. Epileptic Disord 17:117\u2013123. https:\/\/doi.org\/10.1684\/epd.2015.0736","journal-title":"Epileptic Disord"},{"key":"3807_CR2","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/S0140-6736(14)60456-6","volume":"385","author":"SL Moshe","year":"2015","unstructured":"Moshe SL, Perucca E, Ryvlin P, Tomson T (2015) Epilepsy: new advances. Lancet 385:884\u2013898. https:\/\/doi.org\/10.1016\/S0140-6736(14)60456-6","journal-title":"Lancet"},{"key":"3807_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/epd2.20045","volume":"25","author":"FA Nascimento","year":"2023","unstructured":"Nascimento FA, Friedman D, Peters JM et al (2023) Focal epilepsies: update on diagnosis and classification. Epileptic Disord 25:1\u201317. https:\/\/doi.org\/10.1002\/epd2.20045","journal-title":"Epileptic Disord"},{"key":"3807_CR4","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1111\/epi.17241","volume":"63","author":"N Specchio","year":"2022","unstructured":"Specchio N, Wirrell EC, Scheffer IE et al (2022) International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: position paper by the ILAE Task Force on Nosology and Definitions. Epilepsia 63:1398\u20131442. https:\/\/doi.org\/10.1111\/epi.17241","journal-title":"Epilepsia"},{"key":"3807_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0140-6736(00)02515-0","volume":"356","author":"MJ Brodie","year":"2000","unstructured":"Brodie MJ, French JA (2000) Management of epilepsy in adolescents and adults. The Lancet 356:323\u2013329. https:\/\/doi.org\/10.1016\/S0140-6736(00)02515-0","journal-title":"The Lancet"},{"key":"3807_CR6","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1001\/jamaneurol.2014.808","volume":"71","author":"JM Margolis","year":"2014","unstructured":"Margolis JM, Chu B-C, Wang ZJ et al (2014) Effectiveness of antiepileptic drug combination therapy for partial-onset seizures based on mechanisms of action. JAMA Neurol 71:985\u2013993. https:\/\/doi.org\/10.1001\/jamaneurol.2014.808","journal-title":"JAMA Neurol"},{"key":"3807_CR7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1136\/archdischild-2022-324427","volume":"108","author":"KEA Jones","year":"2023","unstructured":"Jones KEA, Howells R, Mallick AA et al (2023) NICE guideline review: epilepsies in children, young people and adults NG217. Arch Dis Child-Educ Pract Ed 108:416\u2013421. https:\/\/doi.org\/10.1136\/archdischild-2022-324427","journal-title":"Arch Dis Child-Educ Pract Ed"},{"key":"3807_CR8","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ-Br Med J 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ-Br Med J"},{"key":"3807_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yebeh.2018.01.029","volume":"81","author":"S Jozwiak","year":"2018","unstructured":"Jozwiak S, Veggiotti P, Moreira J et al (2018) Effects of adjunctive eslicarbazepine acetate on neurocognitive functioning in children with refractory focal-onset seizures. EPILEPSY Behav 81:1\u201311. https:\/\/doi.org\/10.1016\/j.yebeh.2018.01.029","journal-title":"EPILEPSY Behav"},{"key":"3807_CR10","doi-asserted-by":"publisher","first-page":"106962","DOI":"10.1016\/j.yebeh.2020.106962","volume":"105","author":"F Kirkham","year":"2020","unstructured":"Kirkham F, Auvin S, Moreira J et al (2020) Efficacy and safety of eslicarbazepine acetate as adjunctive therapy for refractory focal-onset seizures in children: a double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase-III clinical trial. EPILEPSY Behav 105:106962. https:\/\/doi.org\/10.1016\/j.yebeh.2020.106962","journal-title":"EPILEPSY Behav"},{"key":"3807_CR11","doi-asserted-by":"publisher","first-page":"E1212","DOI":"10.1212\/WNL.0000000000008126","volume":"93","author":"V Farkas","year":"2019","unstructured":"Farkas V, Steinborn B, Flamini JR et al (2019) Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures. Neurology 93:E1212\u2013E1226. https:\/\/doi.org\/10.1212\/WNL.0000000000008126","journal-title":"Neurology"},{"key":"3807_CR12","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1212\/WNL.53.8.1724","volume":"53","author":"M Duchowny","year":"1999","unstructured":"Duchowny M, Pellock JM, Graf WD et al (1999) A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Neurology 53:1724\u20131731. https:\/\/doi.org\/10.1212\/WNL.53.8.1724","journal-title":"Neurology"},{"key":"3807_CR13","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1212\/01.wnl.0000217916.00225.3a","volume":"66","author":"TA Glauser","year":"2006","unstructured":"Glauser TA, Ayala R, Elterman RD et al (2006) Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 66:1654\u20131660. https:\/\/doi.org\/10.1212\/01.wnl.0000217916.00225.3a","journal-title":"Neurology"},{"key":"3807_CR14","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1111\/j.1528-1167.2009.02197.x","volume":"50","author":"PM Levisohn","year":"2009","unstructured":"Levisohn PM, Mintz M, Hunter SJ et al (2009) Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial. Epilepsia 50:2377\u20132389. https:\/\/doi.org\/10.1111\/j.1528-1167.2009.02197.x","journal-title":"Epilepsia"},{"key":"3807_CR15","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1111\/j.1528-1167.2008.01981.x","volume":"50","author":"JE Pina-Garza","year":"2009","unstructured":"Pina-Garza JE, Nordli DR, Rating D et al (2009) Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures. Epilepsia 50:1141\u20131149. https:\/\/doi.org\/10.1111\/j.1528-1167.2008.01981.x","journal-title":"Epilepsia"},{"key":"3807_CR16","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1212\/WNL.54.12.2237","volume":"54","author":"TA Glauser","year":"2000","unstructured":"Glauser TA, Nigro M, Sachdeo R et al (2000) Adjunctive therapy with oxcarbazepine in children with partial seizures. Neurology 54:2237\u20132244. https:\/\/doi.org\/10.1212\/WNL.54.12.2237","journal-title":"Neurology"},{"key":"3807_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3805\/eands.11.30","volume":"11","author":"T Fujiwara","year":"2019","unstructured":"Fujiwara T, Teshima R, Sugiyama I et al (2019) Oxcarbazepine adjunctive therapy for partial seizures in Japanese pediatric patients: a randomized double-blind placebo-controlled study and open-label extension study. Epilepsy Seizure 11:30\u201345. https:\/\/doi.org\/10.3805\/eands.11.30","journal-title":"Epilepsy Seizure"},{"key":"3807_CR18","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1111\/epi.13417","volume":"57","author":"L Lagae","year":"2016","unstructured":"Lagae L, Villanueva V, Meador KJ et al (2016) Adjunctive perampanel in adolescents with inadequately controlled partial-onset seizures: a randomized study evaluating behavior, efficacy, and safety. Epilepsia 57:1120\u20131129. https:\/\/doi.org\/10.1111\/epi.13417","journal-title":"Epilepsia"},{"key":"3807_CR19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ejpn.2015.02.008","volume":"19","author":"W Rosenfeld","year":"2015","unstructured":"Rosenfeld W, Conry J, Lagae L et al (2015) Efficacy and safety of perampanel in adolescent patients with drug-resistant partial seizures in three double-blind, placebo-controlled, phase III randomized clinical studies and a combined extension study. Eur J Paediatr Neurol 19:435\u2013445. https:\/\/doi.org\/10.1016\/j.ejpn.2015.02.008","journal-title":"Eur J Paediatr Neurol"},{"key":"3807_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1177\/0883073818821035","volume":"34","author":"J Antinew","year":"2019","unstructured":"Antinew J, Pitrosky B, Knapp L et al (2019) Pregabalin as adjunctive treatment for focal onset seizures in pediatric patients: a randomized controlled trial. J Child Neurol 34:248\u2013255. https:\/\/doi.org\/10.1177\/0883073818821035","journal-title":"J Child Neurol"},{"key":"3807_CR21","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1111\/epi.12830","volume":"55","author":"D Mann","year":"2014","unstructured":"Mann D, Liu J, Chew ML et al (2014) Safety, tolerability, and pharmacokinetics of pregabalin in children with refractory partial seizures: a phase 1, randomized controlled study. Epilepsia 55:1934\u20131943. https:\/\/doi.org\/10.1111\/epi.12830","journal-title":"Epilepsia"},{"key":"3807_CR22","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/epi.16466","volume":"61","author":"D Mann","year":"2020","unstructured":"Mann D, Antinew J, Knapp L et al (2020) Pregabalin adjunctive therapy for focal onset seizures in children 1 month to <4 years of age: a double-blind, placebo-controlled, video-electroencephalographic trial. Epilepsia 61:617\u2013626. https:\/\/doi.org\/10.1111\/epi.16466","journal-title":"Epilepsia"},{"key":"3807_CR23","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1212\/WNL.52.7.1338","volume":"52","author":"RD Elterman","year":"1999","unstructured":"Elterman RD, Glauser TA, Wyllie E et al (1999) A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Neurology 52:1338\u20131344. https:\/\/doi.org\/10.1212\/WNL.52.7.1338","journal-title":"Neurology"},{"key":"3807_CR24","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1212\/WNL.0b013e3181d1cd4c","volume":"74","author":"E Novotny","year":"2010","unstructured":"Novotny E, Renfroe B, Yardi N et al (2010) Randomized trial of adjunctive topiramate therapy in infants with refractory partial seizures. Neurology 74:714\u2013720. https:\/\/doi.org\/10.1212\/WNL.0b013e3181d1cd4c","journal-title":"Neurology"},{"key":"3807_CR25","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1111\/epi.12233","volume":"54","author":"R Guerrini","year":"2013","unstructured":"Guerrini R, Rosati A, Segieth J et al (2013) A randomized phase III trial of adjunctive zonisamide in pediatric patients with partial epilepsy. Epilepsia 54:1473\u20131480. https:\/\/doi.org\/10.1111\/epi.12233","journal-title":"Epilepsia"},{"key":"3807_CR26","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1080\/14737175.2024.2326606","volume":"24","author":"S Matricardi","year":"2024","unstructured":"Matricardi S, Scorrano G, Prezioso G et al (2024) The latest advances in the pharmacological management of focal epilepsies in children: a narrative review. Expert Rev Neurother 24:371\u2013381","journal-title":"Expert Rev Neurother"},{"key":"3807_CR27","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1586\/ERN.09.114","volume":"9","author":"T Granata","year":"2009","unstructured":"Granata T, Marchi N, Carlton E et al (2009) Management of the patient with medically refractory epilepsy. Expert Rev Neurother 9:1791\u20131802. https:\/\/doi.org\/10.1586\/ERN.09.114","journal-title":"Expert Rev Neurother"},{"key":"3807_CR28","doi-asserted-by":"publisher","first-page":"e00419","DOI":"10.1002\/brb3.419","volume":"6","author":"A Warshavsky","year":"2016","unstructured":"Warshavsky A, Eilam A, Gilad R (2016) Lamotrigine as monotherapy in clinical practice: efficacy of various dosages in epilepsy. Brain Behav 6:e00419. https:\/\/doi.org\/10.1002\/brb3.419","journal-title":"Brain Behav"},{"key":"3807_CR29","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3390\/ph15040475","volume":"15","author":"I Jatziri Contreras-Garcia","year":"2022","unstructured":"Jatziri Contreras-Garcia I, Cardenas-Rodriguez N, Romo-Mancillas A et al (2022) Levetiracetam mechanisms of action: from molecules to systems. Pharmaceuticals 15:475. https:\/\/doi.org\/10.3390\/ph15040475","journal-title":"Pharmaceuticals"},{"key":"3807_CR30","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1684\/j.1950-6945.2003.tb00026.x","volume":"5","author":"E Perucca","year":"2003","unstructured":"Perucca E, Johannessen SI (2003) The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come? Epileptic Disord 5:S17\u2013S26","journal-title":"Epileptic Disord"},{"key":"3807_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.seizure.2022.03.024","volume":"98","author":"Y-F Bai","year":"2022","unstructured":"Bai Y-F, Zeng C, Jia M, Xiao B (2022) Molecular mechanisms of topiramate and its clinical value in epilepsy. Seizure-Eur J Epilepsy 98:51\u201356. https:\/\/doi.org\/10.1016\/j.seizure.2022.03.024","journal-title":"Seizure-Eur J Epilepsy"},{"key":"3807_CR32","unstructured":"Drugs for the treatment of partial onset seizures: extrapolation of efficacy from adults to pediatric patients 1 month of age and older guidance for industry. https:\/\/www.fda.gov\/media\/130449\/download"},{"key":"3807_CR33","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/epi.13981","volume":"59","author":"A Rosati","year":"2018","unstructured":"Rosati A, Ilvento L, Lucenteforte E et al (2018) Comparative efficacy of antiepileptic drugs in children and adolescents: a network meta-analysis. Epilepsia 59:297\u2013314. https:\/\/doi.org\/10.1111\/epi.13981","journal-title":"Epilepsia"},{"key":"3807_CR34","doi-asserted-by":"publisher","first-page":"978876","DOI":"10.3389\/fphar.2022.978876","volume":"13","author":"L Zhang","year":"2022","unstructured":"Zhang L, Li Y, Wang W, Wang C (2022) Comparative antiseizure medications of adjunctive treatment for children with drug-resistant focal-onset seizures: a systematic review and network meta-analysis. Front Pharmacol 13:978876. https:\/\/doi.org\/10.3389\/fphar.2022.978876","journal-title":"Front Pharmacol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-025-03807-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-025-03807-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-025-03807-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T07:11:29Z","timestamp":1742368289000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-025-03807-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["3807"],"URL":"https:\/\/doi.org\/10.1007\/s00228-025-03807-9","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"7 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval is not applicable because this study is based on published literature.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"No informed consent was required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}